Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Presolicitation opportunity from Department Of Health And Human Services was posted on October 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

RNA sequencing and whole genome sequencing services

Awarded
75N98027Q00043Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 32599
New
Federal
SLAC_NOV2026_CHEMICAL_INVENTORY_SYSTEM (CIS)
Solicitation # SLAC_NOV2026_CHEMICAL_INVENTORY_SYSTEM_(CIS)
The SLAC National Accelerator Laboratory, operated by Stanford University for the Department of Energy, is seeking a strategic long-term partnership with a Chemical Inventory System (CIS) provider. The objective is to implement a web-based interface to manage chemicals, cryogens, and compressed gases across approximately 100 delivery locations at SLAC and 15 at Stanford University. The system must enhance the security and accountability of hazardous materials, minimize management costs, and improve environmental performance. Key functional requirements include a web-based Safety Data Sheet (SDS) management system, facility-wide reporting, and the ability to generate snapshots for the California Environmental Reporting System (CERS) and Hazardous Materials Business Plan (HMBP). Technical specifications require the system to support comprehensive bar-coding and labeling, including GHS pictograms and secondary labeling in compliance with OSHA Hazard Communication requirements (29 CFR 1910.1200). The system must integrate with SLAC IT security standards, with vendors expected to provide SOC 2 Type II reports, ISO 27001 certifications, or FedRAMP status. Additionally, the provider must adhere to DOE chemical safety management standards and maintain records for three years post-termination. This current solicitation is a Request for Information (RFI) for market research and budgetary planning; as such, it will not result in the immediate execution of a contract. Responses are due by January 8, 2027.
Slac National Accel Labor -Doe Contractor

POSTED

about 14 hours ago

DEADLINE

in about 2 months

AI Contract Overview

Show more

The National Institutes of Health, specifically the National Cancer Institute, intends to award a firm-fixed-price purchase order to Plasmidsaurus Inc. for RNA and whole genome sequencing services. This acquisition supports CRISPR research focused on B-cell lymphoma, specifically investigating translocations involving MYC, BCL6, and BCL2, as well as copy number alterations. The services will be used to characterize genome edits, conduct transcriptomic analysis, and observe the effects of various drugs on gene expression to identify novel biological pathways. The government is pursuing a sole-source acquisition based on the specialized capabilities of the Oxford Nanopore Technologies platform used by Plasmidsaurus, which is cited as a faster and more scalable alternative to traditional sequencing methods. While the intent is to award to a single source, interested parties may submit capability statements to the primary point of contact by November 6, 2026, to demonstrate their ability to meet the technical requirements. An award is anticipated approximately five calendar days after the closing date.

General Info

NIH to award Plasmidsaurus sole-source contract for RNA and whole genome sequencing services.

Contract Value

$24,800

NAICS

32599

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Award Issued Date

Potential End Date

November 8, 2027

Documents

0

No documents available

This contract was awarded without public documents.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • SLAC_NOV2026_CHEMICAL_INVENTORY_SYSTEM (CIS)Open now, due in 52 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseAwarded
Posted

Presolicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA

Full Description

Show more

NOTICE OF INTENT – SOLE-SOURCE ACQUISITION


Notice No.: 75N98027Q00020


The National Institutes of Health (NIH), National Cancer Ibstitute (NCI), intends to award a Firm-Fixed-Price Purchase Order to Plasmidsaurus Inc. for RNA sequencing and whole genome sequencing services for various wild-type, drug-treated cell lines
and samples related to CRISPR research.


Description of the Requirement


The primary objective of this study is to investigate common lymphoma-related translocations involving MYC, BCL6, or BCL2, while also examining copy number alterations and making CNV calls for genes of interest. To achieve this, RNA sequencing will be provided for samples generated in the Staudt laboratory. RNA sequencing is essential for characterizing genome edits and conducting transcriptomic analysis. By utilizing Plasmidsaurus, a faster and more scalable alternative to traditional sequencing methods based on the latest Oxford Nanopore Technologies platform, we aim to generate results that will deepen our understanding of cellular mechanisms involved in B-cell lymphoma and guide future downstream experiments. RNA sequencing and Whole-genome sequencing are required to observe the effects of various drugs on gene expression, identify pathways, and discover novel pathways.


Justification for the Proposed Sole-Source Acquisition


The Government intends to solicit from a single source pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.


Plasmidsaurus uses the latest Oxford Nanopore Technologies platform, a faster, more scalable alternative to traditional sequencing. Using the latest Oxford Nanopore Technologies platform ensures accurate sequencing, which is crucial for reproducible experiments which will significantly advance our understanding of, and treatment for, B-cell lymphoma, which is vital to cancer research at the National Cancer Institute.


Response Information


This notice is not a request for competitive quotations or proposals. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required preventive maintenance and remedial repair services for the specified instrument and meet all applicable technical and operational requirements.


The Government will review timely submissions to determine whether another responsible source is capable of satisfying the requirement and whether a competitive acquisition is appropriate.


The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source can satisfy the requirement.


Capability statements must be submitted electronically to Sign up to see this detail no later than 9:00 a.m. EDT on November 6, 2026.
Please reference Notice No. 75N98027Q00043 in the subject line of the submission.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 334516
New
Federal
Combined Synopsis Solicitation (competitive)
Solicitation # 75N98027Q00093
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, is seeking a firm fix-price contract for the acquisition of sequencing kits under solicitation 75N98027Q00093/PCA-NIA-11864. This competitive procurement is for commercial items and is not a small business set-aside, meaning the requirement is unrestricted. The scope of work includes the procurement of 114 units of cDNA-PCR Sequencing Kit V14 (SQK-PCS114) and 171 units of PromethION Flow Cells Packs DNA (FLO-PRO114M). Technical requirements specify that flow cells must be compatible with Nanopore PromethION 48 sequencers and generate consensus data with a modal accuracy above 99%, while the cDNA-PCR kits must support six reactions and require no more than 10 ng poly(A)+ RNA or 500 ng total RNA as starting material. Award will be based on the best value to the Government, evaluating factors such as price, technical capability, past performance, and delivery schedule. Deliveries are to be made to NIH/NIA in Baltimore, Maryland, and all items must be packaged and marked according to Government specifications, including the contract number and contractor name. Offerors must be registered in the System for Award Management (SAM) and provide their Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), business size certification, and a completed FAR 52.212-3 representation and certification. Proposals must include unit and total pricing, shipping and handling costs, and a delivery timeframe after award.
Analytical Laboratory Instrument Manufacturing

POSTED

about 14 hours ago

DEADLINE

in 17 days
View Details
NAICS: 541714
New
Federal
DNA Sequencing Service
Solicitation # 75N98027Q00090
The National Institutes of Health (NIH) is soliciting a Firm Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract for high-throughput DNA sequencing services, including Sanger DNA sequencing and whole-plasmid sequencing. The scope of work involves processing plasmid DNA, genomic DNA, and PCR-generated material, with requirements for PCR amplification, product purification, and DNA normalization. The contractor is responsible for providing all sample collection and shipping materials, maintaining strict confidentiality of sequencing data, and retaining DNA samples for at least 180 days post-sequencing. Deliverables include specific electronic file formats such as .ab1, .fasta, and raw FASTQ data, alongside a Monthly Status Report submitted to the Contracting Officer's Representative (COR). The contract spans a five-year period from January 4, 2027, to January 3, 2032, with a total estimated value ranging from $184,200.00 to $958,584.20. Performance and delivery are centered at the NIEHS facility in Research Triangle Park, North Carolina. Award selection will be based on a best value tradeoff, where technical capability and past performance are weighted more heavily than price. Technical evaluations will focus on sequencing capability, personnel qualifications, quality assurance/control, and data management. The acquisition is not set aside for small businesses and falls under NAICS code 541714.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 14 hours ago

DEADLINE

in 19 days
View Details

Get AI-powered intelligence on the opportunities still open

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS